Imvax accelerates document reviews for faster regulatory approval

Imvax, a leader in personalized immunotherapies, needed to streamline document reviews and improve version control ahead of an FDA filing. With Ideagen PleaseReview, they accelerated the review process, helping to bring therapies to patients faster.

LOGO_imvax-650x500_apr25

Improved cross-collaboration

SINGLE-IMAGE_discussing-over-digital-tablet-at-laboratory_mar25

65%

faster document review cycles

0

QMS non-conformances

SINGLE-IMAGE_young-female-scientist-filling-chemical-through-pipette_mar25
company overview

About Imvax

Imvax, Inc. is a biopharmaceutical company focused on developing personalized immunotherapies to target solid tumors. Their innovative approach is transforming cancer treatment by delivering life-saving therapies. 

LOGO_imvax-822x175_apr25

Didn't find what you wanted?

Whether you’re curious about features, pricing or implementation, you can speak to our team and we’ll take you through what you need to know.